Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.200
-0.010 (-0.83%)
At close: Sep 10, 2026, 4:00 PM EDT
1.160
-0.040 (-3.33%)
Pre-market: Sep 11, 2026, 4:00 AM EDT
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $4.83 million as of September 10, 2026. Its market cap has increased by 36.45% in one year.
Market Cap
4.83M
Enterprise Value
413.81K
1-Year Change
36.45%
Ranking
Category
Stock Price
$1.20
ChartMarket Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $4.83M, a decrease of -91.60%. That is a compound annual growth rate of -38.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 4.83M | -21.79% |
| Dec 31, 2025 | 6.17M | 124.01% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
| Aug 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Processa Pharmaceuticals | 5.75M |
| Cardio Diagnostics Holdings | 5.50M |
| HCW Biologics | 5.40M |
| Can-Fite BioPharma | 5.27M |
| PharmaCyte Biotech | 5.22M |
| Pulmatrix | 5.08M |
| Liminatus Pharma | 4.98M |
| Cadrenal Therapeutics | 4.35M |